Janssen to work with Resonant on cancer drug validation
Following a J&J Innovation award, Resonant becomes a partner of Janssen to work on the discovery and validation of antibody therapeutics for cancer.
Following a J&J Innovation award, Resonant becomes a partner of Janssen to work on the discovery and validation of antibody therapeutics for cancer.
After one year of collaborative work, Metrion and LifeArc agree to continue research on a joint project focused on neuroscience ion channel drug discovery for another year.